CORCEPT THERAPEUTICS INC Operating Leases, Future Minimum Payments, Remainder of Fiscal Year
CORCEPT THERAPEUTICS INC (CORT) had Operating Leases, Future Minimum Payments, Remainder of Fiscal Year of $346.00 thousand as of 2018-09-30, per its 10-Q filed 2018-11-02.
Discontinued › Notes › Leases
us-gaap:OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear · last filed 2018-11-02
- 2018-09-30: Operating Leases, Future Minimum Payments, Remainder of Fiscal Year $346.00K.
- 2018-06-30: Operating Leases, Future Minimum Payments, Remainder of Fiscal Year $691.00K.
- 2018-03-31: Operating Leases, Future Minimum Payments, Remainder of Fiscal Year $1.03M.
- 2017-09-30: Operating Leases, Future Minimum Payments, Remainder of Fiscal Year $264.00K.
| Period end | Operating Leases, Future Minimum Payments, Remainder of Fiscal Year |
|---|---|
| 2018-09-30 | $346.00K 10-Q · filed 2018-11-02 |
| 2018-06-30 | $691.00K 10-Q · filed 2018-08-09 |
| 2018-03-31 | $1.03M 10-Q · filed 2018-05-09 |
| 2017-09-30 | $264.00K 10-Q · filed 2017-11-03 |
| 2017-06-30 | $528.00K 10-Q · filed 2017-08-02 |
| 2017-03-31 | $703.00K 10-Q · filed 2017-05-02 |
| 2016-09-30 | $200.00K 10-Q · filed 2016-11-02 |
| 2012-06-27 | $202.00K 10-Q · filed 2012-11-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |